Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Feb 04, 2021 1:41pm
206 Views
Post# 32471873

Bullish Update: Details inside from Webinar

Bullish Update: Details inside from WebinarTests in January 2021:                      73,973 from 32 cubes  -   sales $ 7.1 million USD

Presently in operation:                           62 cubes
By February 2021:                                 20 more cubes
By February 2021:                                 25 more cubes

Earnings:                                           To be released in April 2021

Blowfish Technology:                         Testing for 2 months
                                                           Then emergency application 1.5 months later for approval

Uses for blowfish:                               To detect virus
                                                            Future use:   to detect virus for lung diseases (huge market)
                                                                                 to detect virus for tuberculois
                                                                                 to detect virus for flu
                                                                                 to detect virus for cystic fibrosis

                                                           Also working on technology to extract liquid virus from the air
                                                           To ensure safe working area

Most Valuable Asset for MEDV:         Database of clients - Customer Acquisition
                                                           Access to hundreds of thousands of client information

                                                           Will use database to offer medical services
                                                           - telehealth 
                                                           - drive through car
                                                           - mobile medical services

Nutrell Technology:                            Will be used in hotels, restaurants, buildings where there are people
                                                          Also available for people at home


Vaccination:                                       Testing will be around for years
                                                           People will want test for antibodies after the vaccine
                                                           Testing to ensure that virus does not resurface


MAJOR PLAYER INTERESTED:       Pfizer extremely interested in the blowfish technology 
                                                           And for removing virus from area
                                                          

MPO



<< Previous
Bullboard Posts
Next >>